Experts Warn GLP-1 Weight-Loss Use Requires Medical Supervision Beyond Regulatory Compliance

Three young Japanese women were hospitalized with ketoacidosis after using tirzepatide without medical supervision, their cases illuminating a gap that regulations alone cannot close. The drugs that have reshaped obesity medicine suppress appetite powerfully and indiscriminately — and when that suppression meets severe dietary restriction, the body can enter a dangerous metabolic state that no prescription label warns against. Medical experts are now asking a harder question than whether a drug was legally obtained: whether the weight loss it produces is being pursued safely, with adequate nut